Texas sues Eli Lilly for allegedly bribing providers to prescribe its medications
The lawsuit accuses Eli Lilly of an illegal kickback scheme that tainted millions of dollars in Texas Medicaid claims by incentivizing prescriptions of GLP-1 drugs, officials said.
- Texas Attorney General Ken Paxton has filed a lawsuit against Eli Lilly, accusing the company of bribing medical providers to promote its drugs, including Mounjaro and Zepbound, violating state fraud prevention laws and defrauding taxpayers.
- The complaint alleges that Eli Lilly provided illegal incentives, like free nurses, to influence prescribing patterns, resulting in unauthorized reimbursements to the state's Medicaid program under the Texas Health Care Program Fraud Prevention Act.
- The lawsuit claims Eli Lilly's actions resulted in pharmacies and other intermediaries submitting claims that violated Texas Medicaid policy, leading to millions in unauthorized reimbursements.
- Paxton stated that Eli Lilly prioritized corporate greed over health, manipulating the healthcare system for profit at taxpayer expense.
17 Articles
17 Articles
Paxton accuses drug manufacturer of bribing providers in Texas
AUSTIN (KXAN) — On Tuesday, Attorney General Ken Paxton said he filed a lawsuit against Eli Lilly, a pharmaceutical company headquartered in Indiana. According to the AG’s office, Eli Lilly was accused of “bribing and illegally inducing medical providers to prescribe its most profitable drugs.” KXAN reached out to Eli Lilly for a statement. A spokesperson with the company provided the following. “Multiple courts and the federal government have r…
Eli Lilly Bribed Doctors to Prescribe Medications, Texas AG Alleges
Eli Lilly allegedly paid health care providers to recommend and prescribe weight loss drugs, according to a new complaint. An Eli Lilly program that makes available free nursing services to providers who prescribe the glucagon-like peptide-1 (GLP-1) medications illegally induces providers to prescribe the drugs, Texas Attorney General Ken Paxton said in a lawsuit filed on Aug. 12 in a district court in Harrison County. Another program, which giv…
Pharma Giant Sued Over Bribery Allegations; Medicaid $$ for the Dead; Milk and Bones
(MedPage Today) -- Note that some links may require registration or subscription. Texas Attorney General Ken Paxton said the state is suing Eli Lilly for allegedly bribing clinicians to prescribe its GLP-1 drug tirzepatide (Mounjaro, Zepbound...
What's Going On With Eli Lilly Stock Wednesday?
Texas Attorney General Ken Paxton has filed a lawsuit against Eli Lilly and Co. (NYSE:LLY), accusing the pharmaceutical giant of bribing medical providers to promote its most profitable drugs, including the widely used GLP-1 medications Mounjaro and Zepbound for diabetes and weight loss. Paxton alleges the company’s conduct violated state fraud prevention laws and defrauded taxpayers through improper Medicaid claims. According to the complaint, …
Coverage Details
Bias Distribution
- 67% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium